ATS View
한국어

Hyundai Pharmaceutical KRX:004310KOSPI

현대약품 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h2
Articles, 7 days7
DART filings, 7 days0
Articles tracked7since Sep 11

In 2026-05, Hyundai Pharmaceutical reported revenue of ₩55.6bn, up 14.8% year on year, and operating profit of ₩976m. Hyundai Pharmaceutical (현대약품) appeared in 7 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 11 with 4 articles.

Hyundai Pharmaceutical quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
2026-05₩55.6bn+14.8%₩976m₩1.2bn
2026-02₩46.5bn+7.8%₩2.5bn₩420m
2025-11 derived₩48.7bn+13.7%₩43m₩268m
2025-08₩51.6bn+11.6%₩3.5bn₩2.5bn
2025-05₩48.4bn+10.3%₩1.1bn₩956m
2025-02₩43.1bn+0.7%−₩415m−₩985m
2024-11 derived₩42.9bn-5.9%−₩2.0bn−₩1.5bn
2024-08₩46.2bn-2.6%−₩408m−₩487m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Hyundai Pharmaceutical top stories 2 weeks, by number of outlets

  1. 1
    현대약품 아트엠콘서트, 바이올리니스트 유다윤 공연
    4 outlets · 4 articlesFirst report Sep 11 10:24 메디파나뉴스
  2. 2
    현대약품 아트엠콘서트, 17일 유다윤 바이올린 리사이틀
    2 outlets · 2 articlesFirst report Sep 14 08:41 코메디닷컴
  3. 3
    정부, '임신중절 약품' 미프진 도입 추진… 현대약품, 10%대 ↑
    1 outlets · 1 articlesFirst report Sep 15 09:35 머니투데이

Latest Hyundai Pharmaceutical news Korean headlines